your shopping cart is empty.
arrowrightCONTACT
Choose your country Choose your country

Worldwide:
T: +49-30-6392-7878
X: +49-30-6392-7888

USA /Canada:
T: 1.888.578.2660
X: 1.888.578.2666

E-Mail:
peptide@jpt.com

Contact

Content follows

CATALOG PRODUCT FINDER

Back to search list

PepMix™ Pan-HHV6 Select

PepMix™ Pan-HHV6 Select
Qty. Price
1 403,00 €
  
add to cart
 
 
 
Delivery in 2-5 days
Excluding tax
Prices do not include tax. For shipment within Germany 16% MwSt will be included at checkout and in the invoice. For shipment within EU-countries you will need to provide the valid VAT number. International customers should note that all duties, import fees, and taxes are to be paid by the customer
and
shipping fees

PepMix™ Pan-HHV6 Select

Product Code: PM-Pan-HHV6select-1

Virus-specific pool of 99 peptides (defined HLA class I & II-restricted T-cell epitopes) from selected proteins of Human herpesvirus 6B for T cell assays (e.g. ELISPOT).
Amount: 1 vial containing 15 nmol (appr. 25µg) per peptide
Purity: >70% (determined at 220 nm for each peptide)
Delivery Format: Freeze dried in amber type glass vial
Application(s): T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication(s)/Topic(s): Exanthem subitum
Delivery Time: 2-5 days

PepMix™ Select
PepMixes™ Select are able to elicit virus-specific strong immune responses by using only immunodominant epitopes covering various antigens of the same pathogen in one peptide pool. They can be used individually, or in combination, with our market-leading antigen-spanning PepMixes™ to boost an immune response. Applications include generation of virus-specific T cells, pulsing experiments or extended immune monitoring.

Benefits of PepMix™
- Produced under stringent ISO 9001 regulations
- Each peptide quality controlled and guaranteed for identity and purity
- CoA and HPLC-MS data available for each individual peptide batch
- High batch-to-batch consistency
- No false positive T cell responses by contaminating deletion peptides
- No toxic inhibition of T cell responses due to stringent purification of each peptide
- Minimization of endotoxin contamination due to low bioburden process
- ADCF policy in place

PepMix™ Pan-HHV6 Select

References
Read References with
PepMix™ Peptide Pools for Infectious Diseases
COVID-19 related PepMixes™
PepMix™ Control Pools

Application Notes
Peptide Tools to Support the Fight against COVID-19
Alem et al (2020) Full text
Developing Multi-HIV Antigen Specific T-Cells as a Component of a Cure Strategy
Lam et al. (2015) Full text
Peptide-stimulated Expansion of Virus-specific T cells For Preventative Treatment After Allogeneic Stem Cell Transplantation
Gary et al. (2015) Full text

Testimonials
"To establish a novel role for myeloid derived suppressor cells (Pallett et al, Nat. Med. 2015) in chronic viral infection, we utilised the PepMix CEF Pool (extended) as well as a custom synthesized PepMix spanning the core region of HBV genotype D . Whereas, the CEF peptide pool consists of 32 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Cytomegalo, Epstein-Barr, and Influenza virus, the latter custom PepMix included 15meric peptides overlapping by 10 amino acids. Specifically this composition enabled us to monitor both the antiviral CD8+ and CD4+ T cell responses in chronic HBV infection and the non-antigen specific T cells that are known to mediate immunopathology in the liver. Our entire experience with JPT, from ordering/delivery to use in the lab was excellent. Not only were the reagents able to perform reliably and consistently in vitro from batch to batch, the customer and technical support provided was continually available and efficient when needed. JPT will remain our go-to company for purchasing peptides."
Dr. Laura J Pallett, Infection and Immunity, University College London, UK

PepMix™ Pan-HHV6 Select

 
Code
Product Name
 
Price
Buy
PM-HHV6-U54
PepMix™ HHV6 (U54)
Pool of 112 peptides derived from a peptide scan through U54 of Human herpesvirus 6B for T cell assays (antigen specific T-cell stimulation)
add to cart
PM-HHV6-U90
PepMix™ HHV6 (U90)
Pool of 267 peptides derived from a peptide scan through Protein U90 of Human herpesvirus 6B for T cell assays (antigen specific T-cell stimulation)
add to cart
RT-HHV-U54
RepliTope™ HHV6 (U54)
Peptide microarray displaying 112 peptides derived from a peptide scan through U54 of Human herpesvirus 6B
add to cart

Description

Product Code: PM-Pan-HHV6select-1

Virus-specific pool of 99 peptides (defined HLA class I & II-restricted T-cell epitopes) from selected proteins of Human herpesvirus 6B for T cell assays (e.g. ELISPOT).
Amount: 1 vial containing 15 nmol (appr. 25µg) per peptide
Purity: >70% (determined at 220 nm for each peptide)
Delivery Format: Freeze dried in amber type glass vial
Application(s): T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication(s)/Topic(s): Exanthem subitum
Delivery Time: 2-5 days

PepMix™ Select
PepMixes™ Select are able to elicit virus-specific strong immune responses by using only immunodominant epitopes covering various antigens of the same pathogen in one peptide pool. They can be used individually, or in combination, with our market-leading antigen-spanning PepMixes™ to boost an immune response. Applications include generation of virus-specific T cells, pulsing experiments or extended immune monitoring.

Benefits of PepMix™
- Produced under stringent ISO 9001 regulations
- Each peptide quality controlled and guaranteed for identity and purity
- CoA and HPLC-MS data available for each individual peptide batch
- High batch-to-batch consistency
- No false positive T cell responses by contaminating deletion peptides
- No toxic inhibition of T cell responses due to stringent purification of each peptide
- Minimization of endotoxin contamination due to low bioburden process
- ADCF policy in place

References

References
Read References with
PepMix™ Peptide Pools for Infectious Diseases
COVID-19 related PepMixes™
PepMix™ Control Pools

Application Notes
Peptide Tools to Support the Fight against COVID-19
Alem et al (2020) Full text
Developing Multi-HIV Antigen Specific T-Cells as a Component of a Cure Strategy
Lam et al. (2015) Full text
Peptide-stimulated Expansion of Virus-specific T cells For Preventative Treatment After Allogeneic Stem Cell Transplantation
Gary et al. (2015) Full text

Testimonials
"To establish a novel role for myeloid derived suppressor cells (Pallett et al, Nat. Med. 2015) in chronic viral infection, we utilised the PepMix CEF Pool (extended) as well as a custom synthesized PepMix spanning the core region of HBV genotype D . Whereas, the CEF peptide pool consists of 32 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Cytomegalo, Epstein-Barr, and Influenza virus, the latter custom PepMix included 15meric peptides overlapping by 10 amino acids. Specifically this composition enabled us to monitor both the antiviral CD8+ and CD4+ T cell responses in chronic HBV infection and the non-antigen specific T cells that are known to mediate immunopathology in the liver. Our entire experience with JPT, from ordering/delivery to use in the lab was excellent. Not only were the reagents able to perform reliably and consistently in vitro from batch to batch, the customer and technical support provided was continually available and efficient when needed. JPT will remain our go-to company for purchasing peptides."
Dr. Laura J Pallett, Infection and Immunity, University College London, UK

Documentation

Properties

Related Products

PM-HHV6-U54
PepMix™ HHV6 (U54)
Pool of 112 peptides derived from a peptide scan through U54 of Human herpesvirus 6B for T cell assays (antigen specific T-cell stimulation)
add to cart
PM-HHV6-U90
PepMix™ HHV6 (U90)
Pool of 267 peptides derived from a peptide scan through Protein U90 of Human herpesvirus 6B for T cell assays (antigen specific T-cell stimulation)
add to cart
RT-HHV-U54
RepliTope™ HHV6 (U54)
Peptide microarray displaying 112 peptides derived from a peptide scan through U54 of Human herpesvirus 6B
add to cart

News

NEW: SARS-COV-2 B.1.1.7(UK) & HCoV NCAP PepMixesTM

(Jan 2021)
Read more

13 NEW Immunopeptidomics Kits

References for MHC I binding HLA peptides to increase accuracy of neo-epitope identification
(Dec 2020)
Read more

Infectious diseases beyond COVID-19

JPT's peptide formats in the literature
(Oct 2020)
Read more

SARS COV-2 Mass Spec Reference Kit Released!:

SARS-CoV-2 SpikeMix  for Mass Spectrometry covers spike, NCAP, VME-1 & ORF9B
(July 2020)
Read more


> Read more news!

Quality Assurance

All production is performed according to ISO 9001:2015 standards.

ISO 9001

 
Stay in touch and be the first to receive the latest news!

Contact us:

JPT Peptide Technologies GmbH
Volmerstrasse 5
12489 Berlin, Germany
Technical Support:
T: +49-30-6392-7878
X: +49-30-6392-7888
e-mail: peptide@jpt.com
USA & Canada:
T: 1.888.JPT.COM0 (1.888.578.2660)
X: 1.888.JPT.COM6 (1.888.578.2666)
e-mail: peptide@jpt.com